Everbright Securities Initiates Coverage on NEWBORNTOWN (09911) with "Buy" Rating and HK$14.5 Target Price

Stock News10:29

Everbright Securities initiated coverage on NEWBORNTOWN (09911), a leading Chinese social platform company expanding globally, assigning a "Buy" rating with a target price of HK$14.5. As one of the top 10 non-gaming Chinese companies in overseas revenue, NEWBORNTOWN has achieved extensive penetration in emerging social entertainment markets, particularly in the Middle East, North Africa, and Southeast Asia, through refined localization and a successful "product + country" replication strategy. Key highlights from the report include:

1. **Core Social Business**: NEWBORNTOWN operates as a leading global social entertainment platform, primarily serving diverse cultural demographics, especially in MENA. Since 2022, the company has accelerated growth via mergers, acquisitions, and in-house incubation, expanding into gaming and other innovative sectors. In H1 2025, revenue surged 40% YoY to RMB 3.181 billion, with SUGO and TopTop both exceeding 100% revenue growth. Net profit attributable to shareholders reached RMB 489 million, yielding a 15.4% net margin.

2. **Dual-Pronged Social Strategy**: - **Mass Social Segment**: Contributing over 70% of 2024 revenue, this segment employs a "shrub cluster" product matrix (MICO, YoHo, TopTop, SUGO) covering live streaming, voice chat, and gaming-based socializing. The company leverages a "product + country" replication model, focusing on MENA and Southeast Asia, supported by 800+ localized staff across 20+ countries. - **Niche Social Segment**: The acquisition of BlueCity bolstered offerings for LGBTQ+ communities via Blued and Finka, achieving 7.45 million MAUs in 2024, with 47% DAU/MAU and 74% month-on-month retention.

3. **Innovation-Driven Growth**: - **Mobile Games**: The hit title *Alice's Dream: Merge Games* (60% YoY revenue growth in 2024, nearing $10M monthly revenue) exemplifies the "merge+" strategy, with plans to replicate its success. - **Social E-Commerce**: Expansions include BlueCity Health and Mr. Hormone, diversifying user bases. - **AI & Short-Form Video**: NEWBORNTOWN is developing AI Agent tools and the Aippy community while gaining traction in short-video content for Southeast Asia and the Americas.

**Earnings Outlook**: Everbright forecasts 2025-27 revenue of RMB 6.90/8.41/9.70 billion and net profit of RMB 950 million/1.24 billion/1.49 billion, reflecting 97.0%/31.3%/19.7% YoY growth, driven by diversified monetization and high short-to-mid-term visibility.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment